Literature DB >> 15855540

Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal.

C Silva-Costa1, M Ramirez, J Melo-Cristino.   

Abstract

In Portugal erythromycin resistance of 26.6% (n = 352) remained constant during 1998 to 2003, however in 1998 the MLS(B) phenotype dominated (85%), whereas in 2003 the M phenotype prevailed (77%). A decline in T12/emm22 MLS(B) isolates could partially explain the drop in this phenotype, but the rise of the M phenotype was not due to clonal expansion.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15855540      PMCID： PMC1087679          DOI： 10.1128/AAC.49.5.2109-2111.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries.

Authors:  Kensuke Nagai; Peter C Appelbaum; Todd A Davies; Linda M Kelly; Dianne B Hoellman; Arjana Tambic Andrasevic; Liga Drukalska; Waleria Hryniewicz; Michael R Jacobs; Jana Kolman; Jolanta Miciuleviciene; Marina Pana; Lena Setchanova; Marianne Konkoly Thege; Helena Hupkova; Jan Trupl; Pavla Urbaskova
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America.

Authors:  Alan L Bisno; Michael A Gerber; Jack M Gwaltney; Edward L Kaplan; Richard H Schwartz
Journal:  Clin Infect Dis       Date:  2002-07-15       Impact factor: 9.079

3.  Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.

Authors:  J Kataja; P Huovinen; M Skurnik; H Seppälä
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci.

Authors:  B Beall; R R Facklam; J A Elliott; A R Franklin; T Hoenes; D Jackson; L Laclaire; T Thompson; R Viswanathan
Journal:  J Med Microbiol       Date:  1998-10       Impact factor: 2.472

5.  Presence of chromosomal elements resembling the composite structure Tn3701 in streptococci.

Authors:  C Le Bouguénec; G de Cespédès; T Horaud
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

6.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

Authors:  H Seppälä; T Klaukka; J Vuopio-Varkila; A Muotiala; H Helenius; K Lager; P Huovinen
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

7.  Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Li-Na Lee; Pan-Chyr Yang; Shen-Wu Ho; Hung-Chi Lue; Kwen-Tay Luh
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

8.  Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens.

Authors:  J Melo-Cristino; M L Fernandes
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

9.  Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.

Authors:  Edouard Bingen; Philippe Bidet; Liliana Mihaila-Amrouche; Catherine Doit; Samuel Forcet; Naïma Brahimi; Anne Bouvet; Robert Cohen
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates.

Authors:  J Figueira-Coelho; M Ramirez; M J Salgado; J Melo-Cristino
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431
View more
  13 in total

1.  Nonoutbreak surveillance of group A streptococci causing invasive disease in Portugal identified internationally disseminated clones among members of a genetically heterogeneous population.

Authors:  A Friães; M Ramirez; J Melo-Cristino
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

2.  Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.

Authors:  Devrim Dundar; Murat Sayan; Gulden Sonmez Tamer
Journal:  Microb Drug Resist       Date:  2010-07-12       Impact factor: 3.431

3.  The Viriato study: update on antimicrobial resistance of microbial pathogens responsible for community-acquired respiratory tract infections in Portugal.

Authors:  José Melo-Cristino; Letícia Santos; Catarina Silva-Costa; Ana Friães; Marcos D Pinho; Mário Ramirez
Journal:  Paediatr Drugs       Date:  2010-06-29       Impact factor: 3.022

4.  Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes.

Authors:  J A Carriço; C Silva-Costa; J Melo-Cristino; F R Pinto; H de Lencastre; J S Almeida; M Ramirez
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

5.  DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci.

Authors:  T A Figueiredo; S I Aguiar; J Melo-Cristino; M Ramirez
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

6.  Differences between macrolide-resistant and -susceptible Streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption.

Authors:  C Silva-Costa; A Friães; M Ramirez; J Melo-Cristino
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 7.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

8.  Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).

Authors:  Virginia Rubio-López; Sylvia Valdezate; David Alvarez; Pilar Villalón; María José Medina; Celia Salcedo; Juan-Antonio Sáez-Nieto
Journal:  BMC Microbiol       Date:  2012-09-21       Impact factor: 3.605

9.  Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.

Authors:  G Gherardi; D Petrelli; M C Di Luca; F Pimentel de Araujo; P Bernaschi; A Repetto; J Bellesi; L A Vitali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-30       Impact factor: 3.267

10.  Ranked Adjusted Rand: integrating distance and partition information in a measure of clustering agreement.

Authors:  Francisco R Pinto; João A Carriço; Mário Ramirez; Jonas S Almeida
Journal:  BMC Bioinformatics       Date:  2007-02-07       Impact factor: 3.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.